Articles by Baylor College of Medicine

Blocking proteins that activate the AGC group of enzymes has been shown to have tumor-suppressing effects

Identifying the right set of patients using a molecular test can help effectively deliver a personalized, chemotherapy-free treatment regimen

Trial validates localization of NKT cells to tumor sites in humans and points to high in vivo antitumor activity

Proteins and small molecules involved in DNA repair play a key role in creating bacterial mutants with antibiotic resistance

A computer analysis pipeline that helps detect contaminants in samples that contain little microbial DNA

These cancers are less likely to respond to chemotherapy and patient outcomes are poor

Identifying rare variant risk factors in individuals with schizophrenia could lead to better understanding of prognosis

Method known as untargeted metabolomics profiling can improve the diagnostic rate for rare genetic conditions

The analyses revealed new therapeutics targets in different subtypes of breast cancer, a step toward personalized cancer care

Study finds that beginning with RNA sequencing could increase diagnostic yield by 17 percent

Researchers have been working on improving their ability to identify the genetic cause of undiagnosed conditions

A particular combination of two maternal and one fetal gene variants seems to predispose women to preeclampsia

Although the current histopathology system has some success predicting tumor recurrence, there seems to be room for improvement

Baylor researchers' work highlights that heterogeneity of both tumor cells themselves and immune composition of the microenvironment are important considerations for therapy 

Researchers at Baylor College of Medicine have conducted the most comprehensive study of TP53 mutations to better understand the processes leading to the inactivation of this important gene